UKpolicy

News

UK biotech financing shoots up, setting up "a record year"

UK biotech shrugged off a difficult economic environment with a 44% increase in venture capital investment in the third quarter to £270m, says BIA.

News

Clinical trial setup times fall sharply in UK

Reforms to the regulatory framework for clinical research in the UK are starting to deliver, with delivery times down 35%, according to new data.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

News

MHRA lays out its thinking on AI and medicines regulation

An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.

Market Access

Two pills in the middle of multiple £1 coins

UK’s next pricing and access scheme to last for 7 years

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

UK biotech financing shoots up, setting up "a record year"

Clinical trial setup times fall sharply in UK

Building a social presence inside regulatory guardrails

MHRA lays out its thinking on AI and medicines regulation

UK’s next pricing and access scheme to last for 7 years

One year after MFN: How US policy is reshaping the global ph...

Astellas pays $285m for Audax cancer drug, and other deals

Discover a new era of healthcare panel engagement: Grounded ...

UKpolicy

Editor's Picks